Michael Exton bought $50K of LXRX stock

Michael Exton, Chief Executive Officer of Lexicon Pharmaceuticals, Inc. (LXRX), bought 30,064 shares of LXRX stock worth $50K, per an SEC Form 4 filed Nov 9, 2026.

It was an open-market purchase.

The trade happened on Nov 6, 2026, 3 days before it was made public.

LXRX has moved +0.0% since the trade date, from $1.78 to $1.78 (Nov 6, 2026 close).